Novo Nordisk turns RNAi research up to Eleven with new biotech pact

Two years since Novo Nordisk made a push into the ribonucleic acid space spearheaded by its acquisition of Dicerna Pharmaceuticals, the Danish drugmaker has announced a new collaboration to find ways to fine-tune RNA tech.